| Autor: |
Vong S; World Health Organization, Office of South East Asia region, New Delhi, India vongs@who.int., Anciaux A; World Health Organization, Office of South East Asia region, New Delhi, India., Hulth A; Unit for Antibiotics and Infection Control, Public Health Agency, Stockholm, Sweden (WHO Collaborating Centre for AMR containment)., Stelling J; WHO Collaborating Centre for Surveillance of Antimicrobial Resistance, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Thamlikitkul V; Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Gupta S; National Centre for Disease Control, India's Ministry of Health and Family Welfare, New Delhi, India., Fuks JM; Unit for Antibiotics and Infection Control, Public Health Agency, Stockholm, Sweden (WHO Collaborating Centre for AMR containment)., Walia K; Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, Ansarinagar, New Delhi, India., Rattanumpawan P; Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Eremin S; AMR Secretariat, World Health Organization, Geneva, Switzerland., Tisocki K; Essential Drugs and Medicines, World Health Organization, Office of South East Asia region, New Delhi, India., Sedai TR; Health Emergencies Department, World Health Organization, Office of South East Asia region, New Delhi, India., Sharma A; World Health Organization, Office of South East Asia region, New Delhi, India. |
